Ann: Pharma Executive Appointed to Recce Board-RCE.AX, page-3

yes indeed Jig agree fully here, yet another great appointment IMO.

as shown in the announcement:

- - - - - - - - - -

Pharma Executive Appointed to Recce Board

Leading global pharmaceutical executive appointed to Recce’s Board

Perth, Western Australia, 27 May 2016 – Recce Ltd (ASX: RCE) the developer of a new class of patented drugs targeted at antibiotic and anti-cancer human applications, is pleased to announce the appointment of Bernadette Murdoch as an Independent Non-Executive Director.

Bernadette Murdoch is currently Head of Corporate Affairs and Communications, Australasia for Glaxo Smith Kline (GSK). Her understanding of the pharmaceutical industry and experience in scientific communications will be an asset to the Board as Recce approaches clinical human trials for RECCE® 327.

Bernadette has been employed in pharmaceutical Public Relations, Communications and Corporate Affairs as an increasingly senior manager throughout UK, Europe, Middle-East and Africa. Earlier, after graduate qualifications in Public Relations, Bernadette was an associate within global Burson-Marsteller, and later in related consulting roles advised prominent clients CSL, Melbourne Water, Motorola, Australian Telecommunications Association and GSK.

Consistently, Bernadette has won public and corporate awards as she has managed key media and public campaigns, introducing new products relating to children’s health, women’s health and male diseases.

Dr Graham Melrose, Executive Chairman, and his fellow directors are very pleased to welcome Ms Bernadette Murdoch.

Dr Graham Melrose, Executive Chairman commented “This appointment, following on the recent appointment of Dr Dominic Barnes to the Board – Recce is now outstandingly structured and positioned to target its technology against the global health threat from superbugs”.

- - - - - - - - - -

also as per last weeks appointed of a NED, Dr Dominic Barnes.
this also is important as its a real front line appointment which builds the blocks so adding to the above appointment just announced then one should only expect action, results, and confidence as this human trials get kicked off.

as I said in a previous post, my father had done clinical trials so the importance of these moving forward are huge, and even in which case my fathers doctor had even called up my mother to thank her and thank my father after he passed away for participating because the outcome of my father having done such clinical trial has certainly saved many others which likely such list will keep on growing.

great to see the shareprice respecting the news too.
technically looking at the chart the array of previous candles IMO is showing this confidence returning as so next week if we can hit and hold 30c then that should hopefully play new support moving forward I hope in continual gradual moves like the previous trading days